Live Feeds
● LIVE Updated 1d ago · 15 sources tracked

Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates

Eli Lilly stock reached a new all-time high following an EU panel recommendation for expanded use of Jaypirca. The company is among several stocks near buy points as the market rally shifts toward healthcare. Shares rose up to 10.0% following the EU nod and GLP-1 access developments.

RSS Source map (12)

What changed

Eli Lilly stock hit a new all-time high after an EU panel backed the expanded use of Jaypirca.

Live updates

  1. Eli Lilly Shares Rise on EU Panel Support for Jaypirca

    Eli Lilly stock reached a new all-time high following an EU panel recommendation for expanded use of Jaypirca. The company is among several stocks near buy points as the market rally shifts toward healthcare. Shares rose up to 10.0% following the EU nod and GLP-1 access developments.

    What's confirmed:

    • An EU panel backed the expanded use of Jaypirca.
    • The Committee for Medicinal Products for Human Use met from 22-25 June 2026.
    • Eli Lilly stock reached a new all-time high.

    Still unconfirmed:

    • Eli Lilly stock rose 10.0% after an EU CLL nod and GLP-1 access win.
    • Eli Lilly gained 7% on Friday.
    • Eli Lilly shares have gained roughly 6% over the past 30 days.
    • Street expectations suggest more than 13.6% upside for Eli Lilly from current levels.
    confidence 90%